|
Disclaimer: These guidelines were developed under contract using generally accepted secondary sources. The protocol used by the contractor for surveying these data sources was developed by the National Institute for Occupational Safety and Health (NIOSH), the Occupational Safety and Health Administration (OSHA), and the Department of Energy (DOE). The information contained in these guidelines is intended for reference purposes only. None of the agencies have conducted a comprehensive check of the information and data contained in these sources. It provides a summary of information about chemicals that workers may be exposed to in their workplaces. The secondary sources used for supplements 111 and 1V were published before 1992 and 1993, respectively, and for the remainder of the guidelines the secondary sources used were published before September 1996. This information may be superseded by new developments in the field of industrial hygiene. Therefore readers are advised to determine whether new information is available.
OCCUPATIONAL SAFETY AND HEALTH GUIDELINE FOR DICHLORVOS
INTRODUCTION
This guideline summarizes pertinent information about dichlorvos for workers
and employers as well as for physicians, industrial hygienists, and other
occupational safety and health professionals who may need such information to
conduct effective occupational safety and health programs. Recommendations
may be superseded by new developments in these fields; readers are therefore
advised to regard these recommendations as general guidelines and to
determine whether new information is available.
SUBSTANCE IDENTIFICATION
* Formula
C(4)H(7)Cl(2)O(4)P
* Structure
(For Structure, see paper copy)
* Synonyms
2,2-dichlorovinyl dimethyl phosphate; DDVP; dichlorophos; dichlorovas;
vapona; dimethyl dichlorovinyl phosphate
* Identifiers
1. CAS No.: 62-73-7
2. RTECS No.: TC0350000
3. DOT NA: 2783 55 (dichlorvos); DOT UN: 3017 28 (organophosphorus
pesticides, liquid, toxic, not otherwise stated)
4. DOT label: Poison (dichlorvos); Poison, flammable liquid
(organophosphorus pesticides, liquid, toxic, not otherwise stated)
* Appearance and odor
Dichlorvos is a colorless to amber oily liquid with a mild aromatic odor.
CHEMICAL AND PHYSICAL PROPERTIES
* Physical data
1. Molecular weight: 220.98
2. Boiling point (at 20 mm Hg): 140 degrees C (284 degrees F) (decomposes)
3. Specific gravity (water = 1): 1.42 at 25 degrees C (77 degrees F)
4. Vapor density: Not applicable.
5. Melting/Freezing point: Data not available.
6. Vapor pressure at 20 degrees C (68 degrees F): 0.012 mm Hg
7. Solubility: Slightly soluble in water and glycerol; soluble in
kerosene, ethanol, chloroform, and acetone. Miscible with alcohol, aromatic
and chlorinated hydrocarbon solvents, aerosol propellants, and most nonpolar
solvents.
8. Evaporation rate: Data not available.
* Reactivity
1. Conditions contributing to instability: Contact with water or an
alkali causes rapid hydrolyzation.
2. Incompatibilities: None reported.
3. Hazardous decomposition products: Dichlorvos readily decomposes in
strong acids or alkalies. Toxic gases and vapors such as phosphorus,
chlorinated oxides, and carbon monoxide may be released in a fire involving
dichlorvos.
4. Special precautions: Dichlorvos attacks some forms of plastic, rubber,
and coatings. It is corrosive to iron and mild steel.
* Flammability
The National Fire Protection Association has not assigned a
flammability rating to dichlorvos. Other sources rate dichlorvos as
practically nonflammable when this substance is exposed to heat or open
flame.
1. Flash point: Data not available.
2. Autoignition temperature: Data not available.
3. Flammable limits in air: Data not available.
4. Extinguishant: For small fires use dry chemical, water spray, or
regular foam. Use water spray, fog, or regular foam to fight large fires
involving dichlorvos.
Fires involving dichlorvos should be fought upwind from the maximum
distance possible. Keep unnecessary people away; isolate the hazard area and
deny entry. Emergency personnel should stay out of low areas and ventilate
closed spaces before entering. Containers of dichlorvos may explode in the
heat of the fire and should be moved from the fire area if it is possible to
do so safely. If this is not possible, cool fire exposed containers from the
sides with water until well after the fire is out. Stay away from the ends
of containers. Dike fire control water for later disposal; do not scatter
this material. Firefighters should wear a full set of protective clothing and
self-contained breathing apparatus when fighting fires involving
dichlorvos.
EXPOSURE LIMITS
* OSHA PEL
The current Occupational Safety and Health Administration (OSHA)
permissible exposure limit (PEL) for dichlorvos is 1 milligram per cubic
meter (mg/m(3)) of air as an 8-hour time-weighted average (TWA)
concentration. The OSHA PEL also bears a "Skin" notation, which indicates
that the cutaneous route of exposure (including mucous membranes and eyes)
contributes to overall exposure [29 CFR 1910.1000, Table Z-1].
* NIOSH REL
The National Institute for Occupational Safety and Health (NIOSH)
has established a recommended exposure limit (REL) for dichlorvos of 1
mg/m(3) as a TWA for up to a 10-hour workday and a 40-hour workweek. NIOSH
also assigns a skin notation to dichlorvos [NIOSH 1992].
* ACGIH TLV
The American Conference of Governmental Industrial Hygienists
(ACGIH) has assigned dichlorvos a threshold limit value (TLV) of 0.1 ppm
(0.90 mg/m(3)) as a TWA for a normal 8-hour workday and a 40-hour workweek.
The ACGIH also assigns a "Skin" notation to dichlorvos [ACGIH 1994, p.
19].
* Rationale for Limits
The NIOSH limit is based on the risk of cholinesterase inhibition
[NIOSH 1992].
The ACGIH limit is based on the risk of plasma cholinesterase
depression [ACGIH 1991, p. 447].
HEALTH HAZARD INFORMATION
* Routes of Exposure
Exposure to dichlorvos can occur through inhalation, ingestion, eye
or skin contact, and absorption through the skin [Sittig 1991].
* Summary of toxicology
1. Effects on Animals: Dichlorvos is an anticholinesterase agent and may
cause excessive salivation, eye tearing, sweating, constricted pupils,
respiratory distress, anorexia, vomiting, diarrhea, weakness, twitching,
paralysis, a slow and irregular heartbeat, convulsions, coma, and death
[Hathaway et al. 1991]. Dichlorvos also has reproductive effects and causes
malformed offspring in rodents. The acute toxicity of dichlorvos for
laboratory animals is significantly high; the dermal LD(50) for rabbits is
107 mg/kg and 80 mg/kg in rats; and the acute oral LD(50) in rats is 25 mg/kg
[NIOSH 1995; ACGIH 1991; Sax and Lewis 1989]. The lowest single oral dose
that causes observable behavioral changes is 10 mg/kg in calves [NLM 1995].
The neurotoxic effect of dichlorvos on the central and peripheral nervous
system was investigated in acute and subchronic experiments using male rats.
The acute group received a single oral dose of 88 mg/kg and the two
subchronic groups received a daily oral dose of 1.6 mg/kg or 0.8 mg/kg for a
period of 6 weeks. Both the acute and subchronic groups exhibited
significant changes in the functions of the central nervous system, increase
of EEG mean frequency, decrease of EEG amplitude, and peripheral nervous
system decrease of conduction velocity, and increase of relative and absolute
refractory periods. In one of two studies on the long-term effects of
dichlorvos by oral exposure, an increased but not statistically significant
number of squamous-cell tumors were found in mice [ACGIH 1991]. However, the
International Agency for Research on Cancer (IARC) has concluded that the
evidence for the carcinogenicity of dichlorvos in animals is inadequate [IARC
1987]. Administered intraperitoneally during pregnancy, dichlorvos produced
developmental abnormalities in rat fetuses [NIOSH 1995]. Dichlorvos is
mutagenic in bacterial and mammalian test systems [NIOSH 1995; NLM 1995].
2. Effects on Humans: Dichlorvos is an organophosphorus pesticide and is
therefore a cholinesterase inhibitor. Overexposure to this substance causes
symptoms that vary by route of exposure. Inhalation causes ocular and
respiratory symptoms. Ingestion causes gastrointestinal effects, while skin
absorption causes localized sweating and muscle twitching in the area where
entry occurred. If exposure is severe, muscle weakness, twitching,
fasciculation, and paralysis may occur. Paralysis of the respiratory muscles
may cause death. Cardiac irregularities, including complete heart block, may
also occur [Hathaway et al. 1991]. Dichlorvos is easily absorbed through the
skin, gastrointestinal tract, and lungs because of its high volatility
[Parmeggiani 1983]. It is rapidly inactivated by the liver, and persons with
liver disease may be less tolerant of the toxic effects than normal persons
[Gosselin 1984]. Human volunteers exposed for 30 minutes/hour each hour, 10
hours/day for 14 days at concentrations of 0.14 to 0.33 mg/m(3) had no
changes in cholinesterase levels, airway resistance, or vision. At a
concentration of 1 mg/m(3) for 7.5 to 8.5 hours, volunteers experienced a 20-
to 25-percent reduction in cholinesterase levels [ACGIH 1991]. Thirteen
workers exposed over a period of a year to an average concentration of 0.7
mg/m(3) showed decreases of 35 percent and 60 percent, respectively, in red
blood cell and plasma cholinesterase levels [Hathaway et al. 1991]. At a
level of 0.1 ppm, the plasma cholinesterase is reported to drop by 20 percent
[ACGIH 1991]. Daily exposure to dichlorvos at levels insufficient to produce
results on a single-dose basis may produce symptoms after several days
exposure. Continuing exposure after symptoms appear can produce increasingly
severe effects [Hathaway et al. 1991]. Dichlorvos has also been reported to
cause allergic contact dermatitis [ACGIH 1991]. Dichlorvos causes
methylation of DNA in vitro, but there is no evidence of mutagenicity in
humans [Hathaway et al. 1991]. IARC has concluded that there is no adequate
data for evaluating the carcinogenicity of dichlorvos in humans [IARC 1987].
* Signs and symptoms of exposure
1. Acute exposure: Symptoms and signs usually appear within minutes of
exposure but they may be delayed for as long as 12 hours. After inhalation,
the initial symptoms and signs are a feeling of tightness in the chest,
wheezing due to bronchospasm, blurring of vision, tearing, runny nose, and
frontal headache. Ingestion causes sweating, nausea, vomiting, diarrhea,
cramps, urination and defecation, and anorexia within 15 minutes to 2 hours
of exposure. Skin absorption can produce local sweating and muscle
fasciculations within 15 minutes to 2 hours after exposure. Death is usually
caused by respiratory muscle paralysis and consequent asphyxiation.
2. Chronic exposure: Continued exposure to dichlorvos may cause headache,
weakness, decreased memory, easy fatigability, disturbed sleep, loss of
sensation in the skin, and paralysis. Delayed neurological symptoms are
reversible after exposure ceases, but recovery is low and may not be
complete.
EMERGENCY MEDICAL PROCEDURES
* Emergency medical procedures: [NIOSH to supply]
5. Rescue: Remove an incapacitated worker from further exposure and
implement appropriate emergency procedures (e.g., those listed on the
Material Safety Data Sheet required by OSHA's Hazard Communication Standard
[29 CFR 1910.1200]). All workers should be familiar with emergency
procedures, the location and proper use of emergency equipment, and methods
of protecting themselves during rescue operations.
EXPOSURE SOURCES AND CONTROL METHODS
The following operations may involve dichlorvos and lead to worker exposures
to this substance:
* The manufacture and transportation of dichlorvos * Liberated during
formulation and mixing for insecticidal application; used as a fumigant and as an anthelmintic in animals * Liberated during
application on vegetables, animals, agricultural premises, and for outdoor
fogging; used as an insecticide in tablets, rubbing devices, resin strips,
animals collars (e.g., pest or flea collars); used in powder form on animals
and in animal buildings; used in insect baits; used as an insecticide in
restaurants, hospitals, and aircraft * Incorporated into plastic strips
that slowly release vapor for use in disinfection of homes and aircraft
Methods that are effective in controlling worker exposures to dichlorvos,
depending on the feasibility of implementation, are as follows:
* Process enclosure * Local exhaust ventilation * General dilution
ventilation * Personal protective equipment
Workers responding to a release or potential release of a hazardous
substance must be protected as required by paragraph (q) of OSHA's Hazardous
Waste Operations and Emergency Response Standard [29 CFR 1910.120].
Good sources of information about control methods are as follows:
1. ACGIH [1992]. Industrial ventilation--a manual of recommended
practice. 21st ed. Cincinnati, OH: American Conference of Governmental
Industrial Hygienists.
2. Burton DJ [1986]. Industrial ventilation--a self study companion.
Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
3. Alden JL, Kane JM [1982]. Design of industrial ventilation systems.
New York, NY: Industrial Press, Inc.
4. Wadden RA, Scheff PA [1987]. Engineering design for control of
workplace hazards. New York, NY: McGraw-Hill.
5. Plog BA [1988]. Fundamentals of industrial hygiene. Chicago, IL:
National Safety Council.
MEDICAL SURVEILLANCE
OSHA is currently developing requirements for medical surveillance. When
these requirements are promulgated, readers should refer to them for
additional information and to determine whether employers whose employees are
exposed to dichlorvos are required to implement medical surveillance
procedures.
* Medical Screening
Workers who may be exposed to chemical hazards should be monitored
in a systematic program of medical surveillance that is intended to prevent
occupational injury and disease. The program should include education of
employers and workers about work-related hazards, early detection of adverse
health effects, and referral of workers for diagnosis and treatment. The
occurrence of disease or other work-related adverse health effects should
prompt immediate evaluation of primary preventive measures (e.g., industrial
hygiene monitoring, engineering controls, and personal protective equipment).
A medical surveillance program is intended to supplement, not replace, such
measures. To detect and control work-related health effects, medical
evaluations should be performed (1) before job placement, (2) periodically
during the term of employment, and (3) at the time of job transfer or
termination.
* Preplacement medical evaluation
Before a worker is placed in a job with a potential for exposure to
dichlorvos, a licensed health care professional should evaluate and document
the worker's baseline health status with thorough medical, environmental, and
occupational histories, a physical examination, and physiologic and
laboratory tests appropriate for the anticipated occupational risks. These
should concentrate on the function and integrity of the central nervous
system, respiratory system, and blood. Medical surveillance for respiratory
disease should be conducted using the principles and methods recommended by
the American Thoracic Society.
A preplacement medical evaluation is recommended to assess medical
conditions that may be aggravated or may result in increased risk when a
worker is exposed to dichlorvos at or below the prescribed exposure limit.
The health care professional should consider the probable frequency,
intensity, and duration of exposure as well as the nature and degree of any
applicable medical condition. Such conditions (which should not be regarded
as absolute contraindications to job placement) include a history and other
findings consistent with diseases of the central nervous system, respiratory
system, or blood.
* Periodic medical evaluations
Occupational health interviews and physical examinations should be
performed at regular intervals during the employment period, as mandated by
any applicable Federal, State, or local standard. Where no standard exists
and the hazard is minimal, evaluations should be conducted every 3 to 5 years
or as frequently as recommended by an experienced occupational health
physician. Additional examinations may be necessary if a worker develops
symptoms attributable to dichlorvos exposure. The interviews, examinations,
and medical screening tests should focus on identifying the adverse effects
of dichlorvos on the central nervous system, respiratory system, or blood.
Current health status should be compared with the baseline health status of
the individual worker or with expected values for a suitable reference
population.
* Termination medical evaluations
The medical, environmental, and occupational history interviews, the
physical examination, and selected physiologic or laboratory tests that were
conducted at the time of placement should be repeated at the time of job
transfer or termination to determine the worker's medical status at the end
of his or her employment. Any changes in the worker's health status should
be compared with those expected for a suitable reference
population.
* Biological monitoring
Biological monitoring involves sampling and analyzing body tissues
or fluids to provide an index of exposure to a toxic substance or metabolite.
The measurement of red blood cell cholinesterase is a nonspecific,
qualitative indicator of acute or chronic exposure to dichlorvos. Workers
should be removed from further exposure if their red blood cell
cholinesterase activity falls below 70 percent of their baseline
level.
WORKPLACE MONITORING AND MEASUREMENT
Determination of a worker's exposure to airborne dichlorvos is made using an
OSHA Versatile Sampler (OVS-2), 13 mm XAD-2 tube (270/140 mg sections, 20/60
mesh) with a glass fiber filter enclosed. Samples are collected at a maximum
flow rate of 1 liter/minute until a maximum collection volume of 480 liters
is reached. The sample is then treated with toluene. Analysis is conducted
by gas chromatography using a flame photometric detector (GC/FPD). This
method (OSHA #62) is fully validated and is described in the OSHA
Computerized Information System [OSHA 1994]. NIOSH has published a similar
method (Method No. 5600) for the determination of a worker's exposure to
organophosphorus pesticides [NIOSH 1994b].
PERSONAL HYGIENE PROCEDURES
If dichlorvos contacts the skin, workers should immediately wash the
affected areas with large amounts of soap and water.
Clothing contaminated with dichlorvos should be removed immediately, and
provisions should be made for the safe removal of the chemical from the
clothing. Persons laundering the clothes should be informed of the hazardous
properties of dichlorvos, particularly its potential for causing systemic
toxicity (including cholinesterase inhibition) through dermal absorption.
A worker who handles dichlorvos should thoroughly wash hands, forearms, and
face with soap and water before eating, using tobacco products, using toilet
facilities, applying cosmetics, or taking medication.
Workers should not eat, drink, use tobacco products, apply cosmetics, or
take medication in areas where dichlorvos or a solution containing dichlorvos
is handled, processed, or stored.
STORAGE
Dichlorvos should be stored in a cool, dry, well-ventilated area in tightly
sealed containers that are labeled in accordance with OSHA's Hazard
Communication Standard [29 CFR 1910.1200]. Containers of dichlorvos should
be protected from physical damage and heat sources, and should be stored
separately from strong alkalies or strong acids. Empty containers of
dichlorvos should be handled appropriately.
SPILLS AND LEAKS
In the event of a spill or leak involving dichlorvos, persons not wearing
protective equipment and fully-encapsulating, vapor-protective clothing
should be restricted from contaminated areas until cleanup has been
completed. The following steps should be undertaken following a spill or
leak:
1. Notify safety personnel.
2. Remove all sources of heat and ignition.
3. Ventilate potentially explosive atmospheres.
4. Do not touch the spilled material; stop the leak if it is possible to
do so without risk.
5. Use non-sparking tools.
6. Water spray may be used to reduce vapors, but the spray may not prevent
ignition in closed spaces.
7. For small liquid spills, take up with sand or other noncombustible
absorbent material and place into closed containers for later disposal.
8. For large liquid spills, build dikes far ahead of the spill to contain
the dichlorvos for later reclamation or disposal.
SPECIAL REQUIREMENTS
U.S. Environmental Protection Agency (EPA) requirements for emergency
planning, reportable quantities of hazardous releases, community
right-to-know, and hazardous waste management may change over time. Users
are therefore advised to determine periodically whether new information is
available.
* Emergency planning requirements
Employers owning or operating a facility at which there are 1,000
pounds or more of dichlorvos must comply with EPA's emergency planning
requirements [40 CFR Part 355.30].
* Reportable quantity requirements for hazardous releases
A hazardous substance release is defined by EPA as any spilling,
leaking, pumping, pouring, emitting, emptying, discharging, injecting,
escaping, leaching, dumping, or disposing into the environment (including the
abandonment or discarding of contaminated containers) of hazardous
substances. In the event of a release that is above the reportable quantity
for that chemical, employers are required to notify the proper Federal,
State, and local authorities [40 CFR 355.40].
The reportable quantity of dichlorvos is 10 pounds. If an amount
equal to or greater than this quantity is released within a 24-hour period in
a manner that will expose persons outside the facility, employers are
required to do the following:
- Notify the National Response Center immediately at (800)
424-8802 or at (202) 426-2675 in Washington, D.C. [40 CFR 302.6].
- Notify the emergency response commission of the State likely to
be affected by the release [40 CFR 355.40].
- Notify the community emergency coordinator to the local
emergency planning committee (or relevant local emergency response personnel)
of any area likely to be affected by the release [40 CFR 355.40].
* Community right-to-know requirements
Employers who own or operate facilities in SIC codes 20 to 39 that
employ 10 or more workers and that manufacture 25,000 pounds or more of
dichlorvos per calendar year or otherwise use 10,000 pounds or more of
dichlorvos per calendar year are required by EPA [40 CFR Part 372.30] to
submit a Toxic Chemical Release Inventory form (Form R) to EPA reporting the
amount of dichlorvos emitted or released from their facility
annually.
* Hazardous waste management requirements
EPA considers a waste to be hazardous if it exhibits any of the
following characteristics: ignitability, corrosivity, reactivity, or
toxicity as defined in 40 CFR 261.21-261.24. Under the Resource Conservation
and Recovery Act (RCRA) [40 USC 6901 et seq.], EPA has specifically listed
many chemical wastes as hazardous. Although dichlorvos is not specifically
listed as a hazardous waste under RCRA, EPA requires employers to treat waste
as hazardous if it exhibits any of the characteristics discussed
above.
Providing detailed information about the removal and disposal of
specific chemicals is beyond the scope of this guideline. The U.S.
Department of Transportation, EPA, and State and local regulations should be
followed to ensure that removal, transport, and disposal of this substance
are conducted in accordance with existing regulations. To be certain that
chemical waste disposal meets EPA regulatory requirements, employers should
address any questions to the RCRA hotline at (703) 412-9810 (in the
Washington, D.C. area) or toll-free at (800) 424-9346 (outside Washington,
D.C.). In addition, relevant State and local authorities should be contacted
for information on any requirements they may have for the waste removal and
disposal of this substance.
RESPIRATORY PROTECTION
* Conditions for respirator use
Good industrial hygiene practice requires that engineering controls
be used where feasible to reduce workplace concentrations of hazardous
materials to the prescribed exposure limit. However, some situations may
require the use of respirators to control exposure. Respirators must be worn
if the ambient concentration of dichlorvos exceeds prescribed exposure
limits. Respirators may be used (1) before engineering controls have been
installed, (2) during work operations such as maintenance or repair
activities that involve unknown exposures, (3) during operations that require
entry into tanks or closed vessels, and (4) during emergencies. Workers
should only use respirators that have been approved by NIOSH and the Mine
Safety and Health Administration (MSHA).
* Respiratory protection program
Employers should institute a complete respiratory protection program
that, at a minimum, complies with the requirements of OSHA's Respiratory
Protection Standard [29 CFR 1910.134]. Such a program must include
respirator selection, an evaluation of the worker's ability to perform the
work while wearing a respirator, the regular training of personnel,
respirator fit testing, periodic workplace monitoring, and regular respirator
maintenance, inspection, and cleaning. The implementation of an adequate
respiratory protection program (including selection of the correct
respirator) requires that a knowledgeable person be in charge of the program
and that the program be evaluated regularly. For additional information on
the selection and use of respirators and on the medical screening of
respirator users, consult the latest edition of the NIOSH Respirator Decision
Logic [NIOSH 1987b] and the NIOSH Guide to Industrial Respiratory Protection
[NIOSH 1987a].
PERSONAL PROTECTIVE EQUIPMENT
Workers should use appropriate personal protective clothing and equipment
that must be carefully selected, used, and maintained to be effective in
preventing skin contact with dichlorvos. The selection of the appropriate
personal protective equipment (PPE) (e.g., gloves, sleeves, encapsulating
suits) should be based on the extent of the worker's potential exposure to
dichlorvos. There are no published reports on the resistance of various
materials to permeation by dichlorvos.
To evaluate the use of PPE materials with dichlorvos, users should consult
the best available performance data and manufacturers' recommendations.
Significant differences have been demonstrated in the chemical resistance of
generically similar PPE materials (e.g., butyl) produced by different
manufacturers. In addition, the chemical resistance of a mixture may be
significantly different from that of any of its neat components.
Any chemical-resistant clothing that is used should be periodically
evaluated to determine its effectiveness in preventing dermal contact. Safety
showers and eye wash stations should be located close to operations that
involve dichlorvos.
Splash-proof chemical safety goggles or face shields (20 to 30 cm long,
minimum) should be worn during any operation in which a solvent, caustic, or
other toxic substance may be splashed into the eyes.
In addition to the possible need for wearing protective outer apparel (e.g.,
aprons, encapsulating suits), workers should wear work uniforms, coveralls,
or similar full-body coverings that are laundered each day. Employers should
provide lockers or other closed areas to store work and street clothing
separately. Employers should collect work clothing at the end of each work
shift and provide for its laundering. Laundry personnel should be informed
about the potential hazards of handling contaminated clothing and instructed
about measures to minimize their health risk.
Protective clothing should be kept free of oil and grease and should be
inspected and maintained regularly to preserve its effectiveness.
Protective clothing may interfere with the body's heat dissipation,
especially during hot weather or during work in hot or poorly ventilated work
environments.
REFERENCES
ACGIH [1991]. Documentation of the threshold limit values and biological
exposure indices. 6th ed. Cincinnati, OH: American Conference of
Governmental Industrial Hygienists.
ACGIH [1994]. 1994-1995 Threshold limit values for chemical substances and
physical agents and biological exposure indices. Cincinnati, OH: American
Conference of Governmental Industrial Hygienists.
ATS [1987]. Standardization of spirometry -- 1987 update. American
Thoracic Society. Am Rev Respir Dis 136:1285-1296.
CFR. Code of Federal regulations. Washington, DC: U.S. Government
Printing Office, Office of the Federal Register.
DOT [1993]. 1993 Emergency response guidebook, guides 28, 55. Washington,
DC: U.S. Department of Transportation, Office of Hazardous Materials
Transportation, Research and Special Programs Administration.
Gosselin RE, Smith RP, Hodge HC [1984]. Clinical toxicology of commercial
products. 5th ed. Baltimore, MD: Williams & Wilkins.
Hathaway GJ, Proctor NH, Hughes JP, and Fischman ML [1991]. Proctor and
Hughes' chemical hazards of the workplace. 3rd ed. New York, NY: Van
Nostrand Reinhold.
IARC [1979]. IARC monographs on the evaluation of carcinogenic risk of
chemicals to man. Volume 20. Lyon, France: World Health Organization,
International Agency for Research on Cancer.
IARC [1987]. IARC monographs on the evaluation of carcinogenic risk of
chemicals to man. Supplement 7. Lyon, France: World Health Organization,
International Agency for Research on Cancer.
Mickelsen RL, Hall RC [1987]. A breakthrough time comparison of nitrile and
neoprene glove materials produced by different glove manufacturers. Am Ind
Hyg Assoc J 48(11): 941-947.
Mickelsen RL, Hall RC, Chern RT, Myers JR [1991]. Evaluation of a simple
weight-loss method for determining the permeation of organic liquids through
rubber films. Am Ind Hyg Assoc J 52(10): 445-447.
NIOSH [1987a]. NIOSH guide to industrial respiratory protection.
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health
Service, Centers for Disease Control, National Institute for Occupational
Safety and Health, DHHS (NIOSH) Publication No. 87-116.
NIOSH [1987b]. NIOSH respirator decision logic. Cincinnati, OH: U.S.
Department of Health and Human Services, Public Health Service, Centers for
Disease Control, National Institute for Occupational Safety and Health, DHHS
(NIOSH) Publication No. 87-108.
NIOSH [1992]. Recommendations for occupational safety and health:
Compendium of policy documents and statements. Cincinnati, OH: U.S.
Department of Health and Human Services, Public Health Service, Centers for
Disease Control, National Institute for Occupational Safety and Health, DHHS
(NIOSH) Publication No. 92-100.
NIOSH [1994a]. NIOSH pocket guide to chemical hazards. Cincinnati, OH:
U.S. Department of Health and Human Services, Public Health Service, Centers
for Disease Control, National Institute for Occupational Safety and Health,
DHHS (NIOSH) Publication No. 94-116.
NIOSH [1994b]. NIOSH manual of analytical methods. 4th ed. Cincinnati, OH:
U.S. Department of Health and Human Services, Public Health Service, Centers
for Disease Control, National Institute for Occupational Safety and Health,
DHHS (NIOSH) Publication No. 94-113.
NIOSH [1995]. Registry of toxic effects of chemical substances: Dichlorvos.
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health
Service, Centers for Disease Control, National Institute for Occupational
Safety and Health, Division of Standards Development and Technology Transfer,
Technical Information Branch.
NJDH [1987]. Hazardous substance fact sheet: Dichlorvos. Trenton, NJ: New
Jersey Department of Health.
NLM [1995]. Hazardous substances data bank: Dichlorvos. Bethesda, MD:
National Library of Medicine.
OSHA [1994]. Computerized information system. Washington, DC: U.S.
Department of Labor, Occupational Safety and Health Administration.
Sax NI, Lewis RJ [1989]. Dangerous properties of industrial materials. 7th
ed. New York, NY: Van Nostrand Reinhold Company.
Sittig M [1991]. Handbook of toxic and hazardous chemicals. 3rd ed. Park
Ridge, NJ: Noyes Publications.
USC. United States code. Washington. DC: U.S. Government Printing Office.
USCG [1984]. CHRIS (chemical hazards response information system) hazardous
chemical data manual: dichlorvos. Washington, DC: U.S. Department of
Transportation, U.S. Coast Guard, Commandant Instruction M16465.12A.
Windholz M, ed. [1983]. Merck Index 10th ed. Rahway, NJ: Merck & Company.
|